Home
>
National Drug Code (NDC)
>
Fexofenadine HCl and Pseudoephedrine HCl
Fexofenadine HCl and Pseudoephedrine HCl - 55111-572-05 - (Fexofenadine HCl and Pseudoephedrine HCl)
Drug Information of Fexofenadine HCl and Pseudoephedrine HCl
| Product NDC: | 55111-572 |
| Proprietary Name: | Fexofenadine HCl and Pseudoephedrine HCl |
| Non Proprietary Name: | Fexofenadine HCl and Pseudoephedrine HCl |
| Active Ingredient(s): | 180; 240 mg/1; mg/1 & nbsp; Fexofenadine HCl and Pseudoephedrine HCl |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Fexofenadine HCl and Pseudoephedrine HCl
| Product NDC: | 55111-572 |
| Labeler Name: | Dr.Reddy's Laboratories Limited |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA079043 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110128 |
Package Information of Fexofenadine HCl and Pseudoephedrine HCl
| Package NDC: | 55111-572-05 |
| Package Description: | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (55111-572-05) |
NDC Information of Fexofenadine HCl and Pseudoephedrine HCl
| NDC Code | 55111-572-05 |
| Proprietary Name | Fexofenadine HCl and Pseudoephedrine HCl |
| Package Description | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (55111-572-05) |
| Product NDC | 55111-572 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Fexofenadine HCl and Pseudoephedrine HCl |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20110128 |
| Marketing Category Name | ANDA |
| Labeler Name | Dr.Reddy's Laboratories Limited |
| Substance Name | FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE |
| Strength Number | 180; 240 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC],Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |
